Back to Search Start Over

Terray assembles $120M series B to push AI-powered small molecules into clinic.

Authors :
Masson, Gabrielle
Source :
FierceBiotech; 10/17/2024, pN.PAG-N.PAG, 1p
Publication Year :
2024

Abstract

AI-focused Terray Therapeutics has doubled its series A funds, raking in $120 million aimed at transforming small molecule drug development. [ABSTRACT FROM AUTHOR]

Subjects

Subjects :
SMALL molecules
VENTURE capital
ARTIFICIAL intelligence
DRUG development

Details

Language :
English
Database :
Complementary Index
Journal :
FierceBiotech
Publication Type :
Periodical
Accession number :
180375424

Tools

Authors Abstract Subjects Details